Marshall Woodworth
2023
In 2023, Marshall Woodworth earned a total compensation of $154.5K as Chief Financial Officer at NeuroBo Pharmaceuticals.
Compensation breakdown
| Other | $154,500 |
|---|---|
| Total | $154,500 |
Woodworth received $154.5K in other compensation, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Marshall Woodworth's compensation ranked 2,850th out of 3,006 executives tracked by ExecPay. In other words, Woodworth earned more than 5.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,850 out of 3,006 | 5th |
Division Manufacturing | 1,580 out of 1,650 | 4th |
Major group Chemicals And Allied Products | 881 out of 918 | 4th |
Industry group Drugs | 851 out of 881 | 3rd |
Industry Pharmaceutical Preparations | 613 out of 637 | 4th |
Source: SEC filing on April 30, 2024.
Woodworth's colleagues
We found three more compensation records of executives who worked with Marshall Woodworth at NeuroBo Pharmaceuticals in 2023.